- Home
- USEG vs RNXT Comparison
USEG vs RNXT Comparison
Compare USEG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEG
- RNXT
- Stock Information
- Founded
- USEG 1966
- RNXT 2012
- Country
- USEG United States
- RNXT United States
- Employees
- USEG N/A
- RNXT N/A
- Industry
- USEG Oil & Gas Production
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- USEG Energy
- RNXT Health Care
- Exchange
- USEG Nasdaq
- RNXT Nasdaq
- Market Cap
- USEG 40.5M
- RNXT 44.0M
- IPO Year
- USEG N/A
- RNXT 2021
- Fundamental
- Price
- USEG $1.19
- RNXT $1.05
- Analyst Decision
- USEG Strong Buy
- RNXT Strong Buy
- Analyst Count
- USEG 1
- RNXT 2
- Target Price
- USEG $3.50
- RNXT $7.50
- AVG Volume (30 Days)
- USEG 642.3K
- RNXT 579.1K
- Earning Date
- USEG 11-10-2025
- RNXT 11-13-2025
- Dividend Yield
- USEG N/A
- RNXT N/A
- EPS Growth
- USEG N/A
- RNXT N/A
- EPS
- USEG N/A
- RNXT N/A
- Revenue
- USEG $12,542,000.00
- RNXT $662,000.00
- Revenue This Year
- USEG N/A
- RNXT $2,895.35
- Revenue Next Year
- USEG $84.68
- RNXT $313.04
- P/E Ratio
- USEG N/A
- RNXT N/A
- Revenue Growth
- USEG N/A
- RNXT N/A
- 52 Week Low
- USEG $0.98
- RNXT $0.75
- 52 Week High
- USEG $6.40
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- USEG 47.13
- RNXT 45.33
- Support Level
- USEG $1.17
- RNXT $1.12
- Resistance Level
- USEG $1.37
- RNXT $1.15
- Average True Range (ATR)
- USEG 0.06
- RNXT 0.07
- MACD
- USEG 0.00
- RNXT -0.01
- Stochastic Oscillator
- USEG 29.63
- RNXT 28.00
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.